Vaccine News and Research

Latest Vaccine News and Research

Safety and immunogenicity of Moderna vaccines containing mRNA encoding the spike protein of different SARS-CoV-2 strains

Researchers evaluated the safety and immunogenicity of COVID-19 vaccines against SARS-CoV-2 variants of concern.

20 Jul 2022

Study shows Omicron BA.4/5 infection triggers highly cross-reactive neutralizing antibodies

Researchers compared the levels of cross-reactive neutralizing antibodies elicited by SARS-CoV-2 Omicron BA.4 and BA.1 infections.

20 Jul 2022

Omicron-specific mRNA vaccine provides superior immune protection against two viral subvariants

Yale scientists have developed a novel Omicron-specific mRNA vaccine that offers superior immune protection against two viral subvariants than standard mRNA vaccines.

20 Jul 2022

New way to test vaccines may be as rigorous and stringent as exposure to field strains of malaria

Malaria is the deadliest mosquito-borne parasitic infection of humans. In 2021, after a century of research, the World Health Organization (WHO) approved the world's first malaria vaccine.

20 Jul 2022

Potential mRNA vaccines for influenza

Scientists discuss the benefits of shifting the global influenza vaccination system to a mRNA-based platform,

19 Jul 2022

New vaccine shows promise to fight Lassa virus

Researchers at the University of Texas Medical Branch have achieved success with a new vaccine developed to fight Lassa Virus, a pathogen that causes Lassa fever.

19 Jul 2022

CDC experts update on monkeypox in the United States

Scientists working with the CDC provide the latest information about monkeypox in the U.S.

19 Jul 2022

COVID-19 vaccine-boosted neutralizing antibody levels decrease substantially within 3 months

Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substantially within 3 months, according to new clinical trial data.

19 Jul 2022

Gut-lung axis: Using commensal bacteria to reinforce mucosal immunity

A recent study discusses the use of commensal bacteria in the gut and/or respiratory tract to deliver viral antigens to the host, thus acting as vaccines

19 Jul 2022

Study shows how a critical Lassa virus protein drives infection

Lassa fever is a viral illness that is far too common in West Africa. Although it can have a mortality rate of 15 percent in severe cases, up to 90% in pregnant women, and causes deafness in a quarter of survivors, there is no vaccine or antiviral to protect against Lassa virus.

19 Jul 2022

New data shows the substantial protection offered by third and fourth COVID-19 vaccine doses

A third and fourth COVID-19 vaccine dose offered substantial protection among adults with healthy immune systems who were eligible to receive them during Omicron variant evolution in early 2022, according to a new MMWR published today.

19 Jul 2022

Elephant genes could offer new clues to preventing cancer development

Scientists modeling the cancer-suppressing p53 gene identify how the 20 different molecules unique to elephants get activated for increased sensitivity and response against carcinogenic conditions - with implications for cancer treatments in humans.

19 Jul 2022

What is the impact of SARS-CoV-2 variant booster vaccinations?

Researchers conducted preliminary assessments of a booster vaccination with the SARS-CoV-2 variant vaccines.

19 Jul 2022

What is the efficacy of the second, third, and fourth dose of the COVID-19 mRNA vaccine?

Investigators examined the effectiveness of two, three, and four SARS-CoV-2 vaccine doses during the Omicron prevalent phases.

19 Jul 2022

Six-country African study highlights the potential dangers of getting COVID-19 during pregnancy

A new study involving hospitalized women in six African countries from the University of Maryland School of Medicine's (UMSOM) Institute of Human Virology (IHV) showed that pregnant women with SARS-CoV-2, the virus that causes COVID-19, had double the risk of being admitted to the intensive care unit (ICU) and four-times the risk of dying in-hospital than pregnant women who did not have COVID-19.

19 Jul 2022

Should siRNA-based antivirals be added to the COVID toolbox?

A recent study reviewed the existing treatment modalities, including vaccines and antivirals, for SARS-CoV-2 infection.

19 Jul 2022

Fighting monkeypox, sexual health clinics are underfunded and ill-equipped

Clinics that treat sexually transmitted diseases — already struggling to contain an explosive increase in infections such as syphilis and gonorrhea — now find themselves on the front lines in the nation's fight to control the rapidly growing monkeypox outbreak.

19 Jul 2022

Sex matters when it comes to immune responses to vaccines and viral infections

A review published in Frontiers in Aging analyzed the sex differences in the safety, effectiveness, and immunogenicity of influenza and COVID-19 vaccines in older individuals. It also analyzed the way sex brings about the modification of the impact of age-related factors on vaccination.

18 Jul 2022

Reducing barriers to access provincial COVID-19 vaccination data in Canada

Roadblocks to accessing data on vaccine effectiveness from provincial health ministries impede researchers' ability to inform a national pandemic response and maintain public trust, according to an analysis in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.211712.

18 Jul 2022

Wistar scientists reveal a novel ADAR1-SIRT1-p16INK4a axis in regulating cellular senescence

Aging and age-related disorders pose a complex challenge to the biomedical research community. To better understand how senescence is regulated is of high significance to promote healthy aging and treat age-associated disorders.

18 Jul 2022

Vaccine News and Research

Latest Vaccine News and Research

Safety and immunogenicity of Moderna vaccines containing mRNA encoding the spike protein of different SARS-CoV-2 strains

Study shows Omicron BA.4/5 infection triggers highly cross-reactive neutralizing antibodies

Omicron-specific mRNA vaccine provides superior immune protection against two viral subvariants

New way to test vaccines may be as rigorous and stringent as exposure to field strains of malaria

Potential mRNA vaccines for influenza

New vaccine shows promise to fight Lassa virus

CDC experts update on monkeypox in the United States

COVID-19 vaccine-boosted neutralizing antibody levels decrease substantially within 3 months

Gut-lung axis: Using commensal bacteria to reinforce mucosal immunity

Study shows how a critical Lassa virus protein drives infection

New data shows the substantial protection offered by third and fourth COVID-19 vaccine doses

Elephant genes could offer new clues to preventing cancer development

What is the impact of SARS-CoV-2 variant booster vaccinations?

What is the efficacy of the second, third, and fourth dose of the COVID-19 mRNA vaccine?

Six-country African study highlights the potential dangers of getting COVID-19 during pregnancy

Should siRNA-based antivirals be added to the COVID toolbox?

Fighting monkeypox, sexual health clinics are underfunded and ill-equipped

Sex matters when it comes to immune responses to vaccines and viral infections

Reducing barriers to access provincial COVID-19 vaccination data in Canada

Wistar scientists reveal a novel ADAR1-SIRT1-p16INK4a axis in regulating cellular senescence

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in